1 – 50 of 50
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2019
-
Mark
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice
(
- Contribution to journal › Article
-
Mark
High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke
(
- Contribution to journal › Article
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
(
- Contribution to journal › Article
- 2018
-
Mark
Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice
(
- Contribution to journal › Article
-
Mark
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
(
- Contribution to journal › Article
-
Mark
Interleukin-25 reduces Th17 cells and inflammatory responses in human peripheral blood mononuclear cells
(
- Contribution to journal › Article
- 2017
-
Mark
High levels of (un)switched memory B cells are associated with better outcome in patients with advanced atherosclerotic disease
(
- Contribution to journal › Article
-
Mark
Plasma stem cell factor levels are associated with risk of cardiovascular disease and death
(
- Contribution to journal › Article
-
Mark
Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease
(
- Contribution to journal › Article
- 2016
-
Mark
Decreased levels of stem cell factor in subjects with incident coronary events.
(
- Contribution to journal › Article
-
Mark
CD4(+) CD56(+) natural killer T-like cells secreting interferon-γ are associated with incident coronary events.
(
- Contribution to journal › Article
-
Mark
Low Levels of Apolipoprotein B-100 Autoantibodies Are Associated With Increased Risk of Coronary Events.
(
- Contribution to journal › Article
-
Mark
High levels of cathepsin D and cystatin B are associated with increased risk of coronary events.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes.
2016) In Stroke: a journal of cerebral circulation(
- Contribution to journal › Article
-
Mark
High Plasma Levels of Galectin-3 Are Associated with Increased Risk for Stroke after Carotid Endarterectomy.
(
- Contribution to journal › Article
-
Mark
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Endarterectomy patients with elevated levels of circulating IL-16 have fewer cardiovascular events during follow-up
(
- Contribution to journal › Article
-
Mark
Associations between macrophage colony-stimulating factor and monocyte chemotactic protein 1 in plasma and first-time coronary events : A Nested case-control Study
(
- Contribution to journal › Article
- 2015
-
Mark
IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice.
(
- Contribution to journal › Article
-
Mark
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
(
- Contribution to journal › Article
-
Mark
A high quality diet is associated with reduced systemic inflammation in middle-aged individuals.
(
- Contribution to journal › Article
-
Mark
High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events.
(
- Contribution to journal › Article
-
Mark
Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects.
(
- Contribution to journal › Article
-
Mark
IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.
(
- Contribution to journal › Article
-
Mark
Human Carotid Plaques With High Levels of Interleukin-16 Are Associated With Reduced Risk for Cardiovascular Events.
(
- Contribution to journal › Article
- 2014
-
Mark
Circulating CD40+ and CD86+ B Cell Subsets Demonstrate Opposing Associations With Risk of Stroke.
(
- Contribution to journal › Article
- 2013
-
Mark
Association between CD8(+) T cell subsets and cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - A review of the experimental evidence.
(
- Contribution to journal › Article
- 2012
-
Mark
TAP1-Deficiency Does Not Alter Atherosclerosis Development in Apoe(-/-) Mice.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.
(
- Contribution to journal › Article
-
Mark
Elevated CD14++CD16- Monocytes Predict Cardiovascular Events.
(
- Contribution to journal › Article
-
Mark
Mobilization of regulatory T cells in response to carotid injury does not influence subsequent neointima formation.
(
- Contribution to journal › Article
-
Mark
Low Levels of Circulating CD4+FoxP3+ T Cells Are Associated With an Increased Risk for Development of Myocardial Infarction But Not for Stroke.
(
- Contribution to journal › Article
- 2011
-
Mark
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.
(
- Contribution to journal › Article
-
Mark
Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.
(
- Contribution to journal › Article
- 2010
-
Mark
Fc{gamma}RIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
(
- Contribution to journal › Article
-
Mark
Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe(-/-) mice.
(
- Contribution to journal › Article
-
Mark
Weak associations between human leucocyte antigen genotype and acute myocardial infarction.
(
- Contribution to journal › Article
-
Mark
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe-/- mice.
(
- Contribution to journal › Article
- 2009
-
Mark
FCGAMMARIIB Inhibits The Development Of Atherosclerosis In Mice
(
- Contribution to journal › Published meeting abstract
-
Mark
Evidence Of A Role Of T Regulatory Cells Mediating Atheroprotection By APO B 100 Peptide Immunization
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.885-885(
- Contribution to journal › Published meeting abstract
-
Mark
Associations Between Human Leukocyte Antigen (HLA) Genotype And Acute Myocardial Infarction
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.953-953(
- Contribution to journal › Published meeting abstract
-
Mark
Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells.
(
- Contribution to journal › Article
- 2008
-
Mark
Inflammation and immunity in diabetic vascular complications.
(
- Contribution to journal › Article
-
Mark
Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
(
- Contribution to journal › Article
- 2006
-
Mark
Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease
(
- Contribution to journal › Scientific review